Enovix Stock Falls 21% After A Forecast Of Lower Sales And The Cancellation Of Planned Smartphone Tests

The battery maker shifted silicon-anode development toward smart eyewear after its current cells missed an energy-density target.

Share
Enovix Stock Falls 21% After A Forecast Of Lower Sales And The Cancellation Of Planned Smartphone Tests

Enovix, which designs and makes lithium-ion batteries, plunged 21% to $2.00 in Thursday trading, as of 9:54 AM ET, erasing $116 million in market value. The decline followed a forecast for lower fourth-quarter sales in the company's Thursday SEC filing.

Sales Growth Gives Way To Decline

Enovix expects fourth-quarter revenue of $9.0 million to $10.0 million, below the $11.3 million it recorded a year earlier. Management also forecasts an adjusted operating loss of $28.0 million to $31.0 million.

The outlook followed third-quarter sales growth, which Enovix attributed to its drone and defense customers. Those gains leave the company heading into a quarter for which management expects revenue to fall from a year earlier.

Smart Eyewear Takes Development Priority

Failure by its current cells to meet its latest energy-density target led Enovix to abandon planned smartphone field testing. The company shifted its silicon-anode development focus to smart eyewear.

Enovix works directly with phone and device makers on custom battery cells. Its batteries serve smartphones, smart eyewear, defense equipment, industrial products and emerging edge-AI devices.

Its South Korean operations supply cells and battery packs to defense, industrial, medical and wearable customers in South Korea, North America and Europe. Manufacturing and research are concentrated mainly in Malaysia, South Korea and India, with corporate functions at its U.S. headquarters.

A Steep Slide Gets Steeper

Enovix entered Thursday down 65% for the year through Wednesday's close, compared with an 11% gain for the S&P 500. Thursday's selloff was on pace to become its second drop of 10% or more this month; its market value stood at $438.9 million in Thursday trading.

The company's earlier quarterly report showed $9 million in revenue and a $43.1 million net loss for the period ended July 5. Enovix therefore brought both operating losses and a sharply lower share price into its latest results.

A U.S. manufacturer is scheduled to receive its initial shipments of higher-energy aerial-drone cells in early 2027.

Sources

More on Enovix

All Enovix (ENVX) coverage →